Home › Johnson & Johnson Faces Uphill Battle At FDA Advisory Panel
 

Keywords :   


Johnson & Johnson Faces Uphill Battle At FDA Advisory Panel

2014-01-15 00:47:09| Food - Topix.net

The third time may not be the charm. Twice before the FDA has turned down the supplemental new drug application for an acute coronary syndrome indication for Johnson & Johnson's Xarelto .

Tags: panel johnson battle faces

Category:Food and Related Products

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »